Ignite Creation Date:
2024-05-05 @ 11:21 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004867
Status:
COMPLETED
Last Update Posted:
2017-01-24
First Post:
2000-03-07
Brief Title:
Positron Emission Tomography in Determining Stage of Esophageal Cancer
Sponsor:
Alliance for Clinical Trials in Oncology
Organization:
Alliance for Clinical Trials in Oncology
Study Overview
Official Title:
The Utility of Positron Emission Tomography PET in Staging of Patients With Potentially Operable Carcinoma of the Thoracic Esophagus
Status:
COMPLETED
Status Verified Date:
2017-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
RATIONALE Imaging procedures such as positron emission tomography may improve the ability to determine the stage of esophageal cancer
PURPOSE This clinical trial is studying how well fludeoxyglucose F 18 positron emission tomography determines tumor stage in patients with esophageal cancer
PURPOSE This clinical trial is studying how well fludeoxyglucose F 18 positron emission tomography determines tumor stage in patients with esophageal cancer
Detailed Description:
OBJECTIVES
Primary Objective
To evaluate whether FDG-PET imaging can detect lesions that would preclude surgery esophagectomy in patients found to be surgical candidates by standard imaging procedures
Secondary Objective
To use the collected data to generate hypotheses to be used in future studies such as which types of previously undetected lesions FDG-PET imaging is best able to identify
Primary Objective
To evaluate whether FDG-PET imaging can detect lesions that would preclude surgery esophagectomy in patients found to be surgical candidates by standard imaging procedures
Secondary Objective
To use the collected data to generate hypotheses to be used in future studies such as which types of previously undetected lesions FDG-PET imaging is best able to identify
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| CDR0000067526 | REGISTRY | NCI Physician Data Query | None |